This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Keck School of Medicine of the University of Southern California and the American Association for Cancer Research. The Keck School of Medicine of the University of Southern California is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.
CREDIT DESIGNATION STATEMENT
The Keck School of Medicine of the University of Southern California designates this educational activity for a maximum of 54.75 AMA PRA Category 1 Credit(s)™
. Physicians should only claim credit commensurate with their participation in the activity.
STATEMENT OF EDUCATIONAL NEED, TARGET AUDIENCE, AND LEARNING OBJECTIVES
New technologies and the resulting explosion in biological information provide a wealth of tools for the physician, clinician-scientist, and other healthcare professionals regarding the diagnosis, treatment, and prevention of cancer. Continuing education is needed to critically study and appropriately evaluate this research, to inform the development of new clinical applications, and to improve patient care.
Scientists and clinicians engaged in all aspects of clinical investigations pertaining to human cancer as well as the scientific disciplines of cellular, molecular, and tumor biology; carcinogenesis; chemistry; endocrinology; epidemiology and biostatistics; experimental/molecular therapeutics; immunology; prevention and survivorship research; and radiobiology/radiation oncology.
At the conclusion of this educational activity, each participant should be able to:
- Demonstrate a clear understanding of the latest research findings in all areas of cancer research and how this research will impact future decision making in the diagnosis, treatment and prevention of cancer;
- Explain the integration of information from the basic and translational sciences to clinical research and application;
- Analyze the epidemiological implications of cancer incidence;
- Identify the importance of technological advances and their use in accelerating research progress;
- Apply the presented information and research to expedite the development of detection, prevention, and treatment strategies to reduce cancer incidence and mortality; and
- Formulate new strategies that will further scientific and clinical research efforts towards the prevention and early detection of cancer.
It is the policy of the Keck School of Medicine of the University of Southern California that the information presented at the Keck School of Medicine of the University of Southern California-sponsored CME activities will be unbiased and based on scientific evidence. To help participants make judgments about the presence of bias, the Keck School of Medicine of the University of Southern California and the American Association for Cancer Research will provide information that Program and Education Committee members, speakers, and abstract presenters have disclosed about financial relationships they have with commercial entities that produce or market products or devices related to the content of this CME activity. This disclosure information is available in the Proceedings Supplement of the American Association for Cancer Research.
Individuals wishing to receive AMA PRA Category 1 Credit(s)
™ for their attendance at this conference should obtain a Documentation of Attendance and Request for Credit form by writing to email@example.com
. This form must be completed and returned to obtain a Certificate of Attendance.
ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT
Commercial entities that provide unrestricted educational grants in support of this educational activity are listed within the Program.
QUESTIONS ABOUT CME?
Please contact AACR's Administrative Coordinator for CME, at (215) 440-9300 or firstname.lastname@example.org